FFA
APLS

Farther Finance Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Farther Finance Advisors’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-95
Closed -$3.84K – 5981
2026
Q1 		$3.84K Sell
95
-272
-74% -$5.86K ﹤0.01% 4621
2025
Q4 		$9.22K Buy
367
+35
+11% +$821 ﹤0.01% 3979
2025
Q3 		$7.51K Buy
332
+266
+403% +$6.2K ﹤0.01% 3571
2025
Q2 		$1.14K Sell
66
-439
-87% -$8.13K ﹤0.01% 3870
2025
Q1 		$11.5K Buy
505
+329
+187% +$9.09K ﹤0.01% 2678
2024
Q4 		$5.62K Buy
176
+136
+340% +$4.09K ﹤0.01% 2619
2024
Q3 		$1.16K Sell
40
-42
-51% -$1.55K ﹤0.01% 3194
2024
Q2 		$2.98K Sell
82
-6
-7% -$272 ﹤0.01% 2625
2024
Q1 		$5.25K Buy
88
+1
+1% +$64 ﹤0.01% 2043
2023
Q4 		$5.21K Buy
87
+31
+55% +$1.57K ﹤0.01% 1948
2023
Q3 		$2.13K Buy
56
+43
+331% +$1.89K ﹤0.01% 1836
2023
Q2 		$1.18K Hold
13
– – ﹤0.01% 1921
2023
Q1 		$857 Hold
13
– – ﹤0.01% 1885
2022
Q4 		$672 Buy
+13
New +$690 ﹤0.01% 1757

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's APLS Position: Q2 2026 in Review

Farther Finance Advisors sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 95 shares — an estimated $3.84K sold.

Farther Finance Advisors first reported a position in APLS in Q4 2022 and held it in 14 quarters. The position peaked at $11.5K in Q1 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Farther Finance Advisors reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 95 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.84K.
  • Farther Finance Advisors first reported a position in Apellis Pharmaceuticals in Q4 2022 and held it in 14 quarters.
  • Farther Finance Advisors's Apellis Pharmaceuticals position peaked at $11.5K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.